Acute Myeloid Leukemia After Radium-223 Therapy: Case Report

Clin Genitourin Cancer. 2017 Aug;15(4):e723-e726. doi: 10.1016/j.clgc.2016.11.002. Epub 2016 Dec 1.

Authors

Andreas Varkaris¹, Krishna Gunturu², Tarun Kewalramani³, Christopher Tretter²

Affiliations

¹ Department of General Internal Medicine, Lahey Clinic, Burlington, MA; Tufts Medical School, Tufts University, Medford, MA. Electronic address: Andreas.varkaris@lahey.org.
² Department of Oncology, Lahey Clinic, Burlington, MA; Tufts Medical School, Tufts University, Medford, MA.
³ Department of Hematology, Lahey Clinic, Burlington, MA; Tufts Medical School, Tufts University, Medford, MA.

PMID: 28024949
DOI: 10.1016/j.clgc.2016.11.002

No abstract available

Keywords: AML; Microenvironment; Prostate Cancer; Radium-223; Secondary leukemia.

Publication types

Case Reports

MeSH terms

Aged
Bone Neoplasms / radiotherapy
Bone Neoplasms / secondary
Humans
Leukemia, Myeloid, Acute / etiology*
Male
Neoplasms, Second Primary / etiology*
Prostatic Neoplasms, Castration-Resistant / radiotherapy
Radium / administration & dosage
Radium / adverse effects*

Substances

Radium-223
Radium